Sometimes less may be better when it comes to treatment for breast cancer. A new study finds that women who have been diagnosed with early-stage HER2-positive breast cancer did just as well with six ...
Two recent studies offer hope of enhancing both the effectiveness and safety of Herceptin, the drug that helped introduce the era of targeted therapy. Two studies presented Saturday offer hope of ...
The European Society for Medical Oncology kicks off its five-day Vienna conference Friday, and Roche’s stock ticker may be expected to pulse with the conversations. That is, particularly if findings ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced the U.S. Food and Drug Administration (FDA) has approved Herceptin ® ...
BRUSSELS - The targeted drug trastuzumab, or Herceptin, previously shown to prolong survival in advanced breast cancer, dramatically reduced the chances of recurrence in patients with early-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback